Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint

Eisai Co., Ltd. and Biogen Inc. has announced that an Independent Data Monitoring Committee has determined that BAN2401,...

December 22, 2017 | Friday | News
Confo Therapeutics enters into collaboration with Roche

Drug Discovery company, Confo Therapeutics has announced that it has entered into a research collaboration and license a...

December 20, 2017 | Wednesday | News
Researchers show patients' own immune cells can fight deadly cancers

Singapore - Scientists have taken a significant step forward in efforts to harness our own white blood cells to fight de...

December 15, 2017 | Friday | News
Bioelectronic medicine to treat lupus

Singapore - Researchers at Northwell Health's Feinstein Institute for Medical Research are conducting a clinic...

December 15, 2017 | Friday | News
Sirenas receives $1.68 M research grant to accelerate ATLANTIS

Singapore – Sirenas, a biotechnology company harnessing computational approaches to discover therapeutics derived ...

December 13, 2017 | Wednesday | News
Kenalog-40 Injection approved and available through Amneal Biosciences

Singapore - Amneal Biosciences (a US based pharmaceutical manufacturing company) received approval for its Triamcin...

December 13, 2017 | Wednesday | News
FDA approves Sanofi's Admelog

Singapore - The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog, the first follow-on insulin lispr...

December 13, 2017 | Wednesday | News
JW Pharma releases cancer treatment trial results

South Korea based JW Pharmaceuticals recently presented phase 1a/1b clinical trial results for CWP291, a target anticanc...

December 12, 2017 | Tuesday | News
Sanofi ends development of Clostridium difficile vaccine

The pharma giant Sanofi has recently announced that it will terminate its late-stage program for a Clostridium difficile...

December 5, 2017 | Tuesday | News
Pfizer inks drug development and commercialization deal with Basilea Pharma

Global pharmaceutical giant Pfizer has inked a strategic deal with Basilea Pharmaceutical, an international biopharmaceu...

December 1, 2017 | Friday | News
Achievement of Biotech Company: Treat Burns with Pineapples

Nasdaq-listed, Israel-headquartered biotechnology company MediWound Ltd. is attempting to revolutionize the way doctors ...

November 27, 2017 | Monday | News
Khondrion presents Phase II KHENERGY trial data

Clinical stage pharma company, Khondrion focusing on small molecule therapeutics for mitochondrial diseases has announce...

November 23, 2017 | Thursday | News
Novel in vitro model investigates drug candidates for cancer metastasis

Singapore - ATCC, an established and trusted source of biological materials in the R&D community, announced the rele...

November 22, 2017 | Wednesday | News
Gamida Cell appoints Julian Adams as chairman and CEO

Cellular and immune therapeutics company, Gamida Cell has announced the appointment of Julian Adams as chairman and chie...

November 21, 2017 | Tuesday | News
NDA submission for Starpharma’s VivaGel BV

Singapore - Australian biotech company Starpharma submitted its New Drug Application (NDA) with the US FDA through a rol...

November 21, 2017 | Tuesday | News
Mitsubhishi Tanabe Pharma's ALS drug treats more than 1000 people in three months

Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic latera...

November 17, 2017 | Friday | News
Seres Therapeutics, MD Anderson Cancer Center and Parker Institute for Cancer Immunotherapy collaborates

Seres Therapeutics, The University of Texas MD Anderson Cancer Center (MD Anderson), and the Parker Institute ...

November 15, 2017 | Wednesday | News
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies

Life Science company Bayer has entered into an exclusive global collaboration with US based biopharma company Loxo Oncol...

November 15, 2017 | Wednesday | News